Marco Metra

Research interests

Publications

• 2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

  European Journal of Heart Failure · 2024 · 10.1002/ejhf.3024

• 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2023 · https://doi.org/10.1093/eurheartj/ehad195

• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

  European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac244

• 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

  European Journal of Heart Failure · 2022 · https://doi.org/10.1002/ejhf.2333

• Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)02076-1

• Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure

  European Journal of Heart Failure · 2021 · 10.1002/ejhf.2115

• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368

• Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

  European Heart Journal · 2021 · 10.1093/eurheartj/ehab670

• Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

  New England Journal of Medicine · 2020 · 10.1056/nejmoa2025797

• Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

  New England Journal of Medicine · 2020 · 10.1056/nejmoa2030183

• Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

  The Lancet · 2020 · 10.1016/s0140-6736(20)32339-4

• Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

  The Lancet · 2020 · 10.1016/s0140-6736(20)32339-4

• Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)

  JAMA Cardiology · 2020 · 10.1001/jamacardio.2020.1096

• Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

  European Heart Journal · 2020 · 10.1093/eurheartj/ehaa409

• Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

  Autoimmunity Reviews · 2020 · 10.1016/j.autrev.2020.102568

• Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2020 · 10.1002/ejhf.1922

• The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2019 · 10.1002/ejhf.1369

• Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2019 · 10.1002/ejhf.1531

• Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations

  European Journal of Heart Failure · 2019 · 10.1002/ejhf.1494

• Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology

  European Journal of Heart Failure · 2018 · 10.1002/ejhf.1236

• European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions

  European Journal of Heart Failure · 2016 · 10.1002/ejhf.566

• Are Hospitalized or Ambulatory Patients with Heart Failure Treated in Accordance with European Society of Cardiology Guidelines? Evidence from 12 440 Patients of the ESC Heart Failure Long-Term Registry

  European Journal of Heart Failure · 2013 · 10.1093/eurjhf/hft134

• EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

  European Journal of Heart Failure · 2013 · 10.1093/eurjhf/hft050

• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

  The Lancet · 2012 · 10.1016/s0140-6736(12)61855-8

• Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

  New England Journal of Medicine · 2011 · 10.1056/nejmoa1100171

• Assessing and Grading Congestion in Acute Heart Failure: A Scientific Statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine

  European Journal of Heart Failure · 2010 · 10.1093/eurjhf/hfq045

• ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

  Journal of the American College of Cardiology · 2006 · 10.1016/j.jacc.2006.07.010

• ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

  Circulation · 2006 · https://doi.org/10.1161/circulationaha.106.177292

• ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

  EP Europace · 2006 · 10.1093/europace/eul108

• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary

  European Heart Journal · 2006 · 10.1093/eurheartj/ehl176

• Executive summary of the guidelines on the diagnosis and treatment of acute heart failure

  European Heart Journal · 2005 · 10.1093/eurheartj/ehi044

• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

  The Lancet · 2003 · 10.1016/s0140-6736(03)13800-7

Current projects

No projects listed.